Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5,071,025
-
Number of holders
-
349
-
Total 13F shares, excl. options
-
19,229,050
-
Shares change
-
+426,073
-
Total reported value, excl. options
-
$6,397,950,795
-
Value change
-
+$147,523,371
-
Put/Call ratio
-
3.36%
-
Number of buys
-
198
-
Number of sells
-
-122
-
Price
-
$332.74
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q3 2019
391 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q3 2019.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 349 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19,229,050 shares
.
Largest 10 shareholders include BlackRock Inc. (2,099,117 shares), VANGUARD GROUP INC (1,923,249 shares), ATLANTA CAPITAL MANAGEMENT CO L L C (753,292 shares), AMERICAN CENTURY COMPANIES INC (727,542 shares), WELLS FARGO & COMPANY/MN (671,349 shares), STATE STREET CORP (500,852 shares), FMR LLC (494,242 shares), MILLENNIUM MANAGEMENT LLC (471,361 shares), UBS ASSET MANAGEMENT AMERICAS INC (418,505 shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (411,912 shares).
This table shows the top 349 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.